A Long-Term Extension Study for Participants Previously Trea... | Clinical Trial | StuddyBuddy@endsection A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of RDEB

Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Enrolling By Invitation NCT05708677

A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of RDEB

Conditions: RDEB

Sex: All

Ages: 6 Years – N/A

Enrollment: 22

Sponsor: Abeona Therapeutics, Inc

Location: United States

Summary

A Long-Term Extension Study for Participants Previously Treated with EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Eligibility Criteria

Inclusion Criteria:Willing and able to give consent/assent;If under the age of 18, guardian(s) is/are willing and able to give consent;Prior study treatment with EB-101.Exclusion Criteria:Inability to properly follow protocol as determined by the Principal Investigator

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05708677). StuddyBuddy aggregates publicly available trial information.